Announcement of the National Epidermolysis Bullosa Registry  by Carter, D Martin
120 LETTERS TO TH E EDITOR 
Table I. The Resul ts of Keratin ocy te G raftin g 
G raftin g w ith 
Keratinocytes in fib rin nct 
Keratinocy tes in PBS 










PBS = 0.05 M phosphate burrer, pH 7.2, and 0. 1 M sodiulll chloride . 
sodium chlo ride) and res uspended in the fibrin ogen component 
of a hi ghl y concentrated fibrino gen preparation fo r tiss ue sti ckin g 
(Beripl as t, Behrin g). Such suspensions co ntained 70-80% viable 
keratinocytes. Fina ll y, the keratinocyte-fibrinogen suspension (1-8 
X 10(' ce ll s/ ml) was acti va ted by the Ca + + and thro mbin com-
ponents of Beripl as t to form a fibrin net o n th e granul ation tissue 
of th e recipient sur face. 
When KG was used , co mplete epithelializa tion was observed 
w ithin 2 weeks in 8 of 10 patients sufferin g from chro ni c sk in 
defects . Keratinocytes in PBS or fibrino gen (Beriplas t) fail ed to 
improve ep ithelializa tion (Table I). 
As compared w ith tran splantation with cultured skin equi va-
lents, the KG method h a~ so me adva ntages . (1) Multipli cation of 
keratinocytes in vitro is not necessary if the surface area of the 
wound is smaller than 5 cm2 (2) A sufficie nt number o f cells ca n 
be o btained for transplantati on in a sho rter time. (3) In the near 
fut ure it w ill be possible to set up kcratin ocy te cel l banks o f deep-
frozen HLA typed cul tured keratinocy tes. Accordin gly, we be-
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lieve th at the KG method mi g ht be an important step to w ard the 
auto trans plantation of large body surfaces w ith in vitro cultured 
keratinocytes. 
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Announcelnent of the National Epidermolysis Bullosa Registry 
To the Editor: 
T he Laborato ry for In ves tigative Derm atology at The Rockefeller 
Uni vers ity was recentl y awa rd ed a 5-yea r contract by the N ationa l 
Institute of Arthriti s and Muscul os keleta l and Skin Diseases 
(NIAM S), to esta blish a N atio nal E pidermolysis Bu ll osa (EB) 
Reg istry. The Registry, which is headed by D . M artin Ca rter, 
M .D., co mprises a Data Coordin atin g Center (DCC), which is 
based at The Rockefeller Uni ve rsity Hospita l, fo ur geographica ll y 
dispersed C linica l Centers, and a Steering Committee. The DCC 
is responsible for the overa ll o perations of the Registry. The 
C linical Centers are headed by Drs . E . A. Bauer at the Wash-
ing ton Uni vers ity School of Med icine in St. Louis, J. D . Fine at 
the University of Alabama in Birmingham , V. P. Sybert at the 
Uni versity of Washington School o f Med icine in Seattle, and D . 
M. Ca rter in New York. These C lini cal Centers are respon sible 
fo r patient enro llment in th eir cachement areas, patient exami-
nations, and transmittin g inform atio n to th e DCC. The Steering 
Committee wi ll serve in an advisory capacity and w ill include 
scientists, clinicians, and laypersons. The Dystro phic Ep ider-
mo lysis Bullosa Resea rch Association of A merica (DEBRA) , a 
no nprofit vo luntary o rga ni za tion th at promotes EB research and 
provides informati on and suppo rt to afAi cted patients and their 
fa milies, will also parti cipate in Registry activities. 
The Registry wi ll co llect appropriate epidemiologic info rm a-
tion about EB, provide statisti ca l and geneti c informatio n , and 
assess th e econo mic and social impact of EB , while develo ping a 
roster of well-characterized patients w ho are willin g to participate 
in vario us research projects. 
We are committed to develo ping a first-rate Registry, one that 
wi ll at trac t th e interes t and participatio n o f patients, scienti sts , 
and clinicians aro und the wo rld. We ask all o f o ur coll eagues in 
dermatology to assist in the Registry. Correspondence from phy-
sicians and scientists w ho are awa re o f patients w ith EB is invited. 
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